Ruzurgi (Amifampridine)

amifampridine 10 mg tablet, 100 · ORAL · PBS code 13032X

AUTHORITY_REQUIRED

What it costs

AU$2719.56 PBS-determined price per 200 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2022-07-01.
• Repeats: 5.
• PBS program: GE.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Lambert-Eaton myasthenic syndrome (LEMS)

The condition must not be any of: (i) myasthenia gravis, (ii) Guillain-Barre syndrome; AND

Must be treated by a prescriber type identifying as at least one of the following: (i) a clinical immunologist, (ii) a neurologist, (iii) a medical practitioner working under the direct supervision of one of these mentioned specialists.

Sponsor: Lacuna Pharma Pty Ltd ABN 12 646 520 792

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.